The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In addition to basic research to understand the molecular processes of viral hepatitis infection, NIH focuses on development of new vaccines, diagnostics, treatments and other interventions to prevent acute and chronic hepatitis infection and related disease.
In 2021, NIH and the Coalition for Global Hepatitis Elimination launched a new webinar series, Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination. The objectives of the series are to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs.
Six webinars were held during the first year of the webinar series, in the period March-October 2021. Webinar recording and slide presentations are available online for each webinar and can be accessed here.
In 2022, the second year of the webinar series, three webinars were held during the first half of the year. Webinar recording and slide presentations are available online for each webinar and can be accessed here:
- Vaccines Against Hepatitis C Virus: Harnessing Immunity to Eliminate Global Hepatitis C (first webinar, 24 March 2022)
- Hepatitis C Elimination at the Intersection of People Who Use Drugs and the Criminal Justice System (second webinar, 5 May 2022)
- Leaving No One Behind: Culture and Context Count in Tailoring Hepatitis Interventions (third webinar, 16 June 2022)